# Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells

> **NCT05774509** · PHASE1 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 12 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **BIOLOGICAL:** Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells

## Key facts

- **NCT ID:** NCT05774509
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-31
- **Primary completion:** 2025-08-15
- **Final completion:** 2026-07-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774509, "Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05774509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*